Fibrous Dysplasia
8
3
3
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Fibrous Dysplasia: An Epidemiological and Correlational Study of Multimodal Data
Study of Denosumab for Prevention of Skeletal Disease Progression in Children With Fibrous Dysplasia
Fibrous Dysplasia, McCune-Albright Syndrome Patient Registry
DEnosumab for the Treatment of FIbrous Dysplasia/McCune-Albright Syndrome in Adults (DeFiD)
Df-Life : Quality of Life in Patients With Fibrous Dysplasia
A Post Market Clinical Follow-up Study on Biomet Microfixation HTR PEKK (Midface), Facial & Mandibular Plates.
Determination of Circulating Autotaxin in Patients With GNAS or PTH Abnormalities
Characterization of Diabetes Mellitus in Fibrous Dysplasia/McCune-Albright Syndrome